Research peptide · Melanocortin research
Bremelanotide
Also known as PT-141 · Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
A synthetic cyclic heptapeptide of the melanocortin lactam series, differing from melanotan II by a free C-terminal acid in place of the carboxamide.
- Compound type
- Research peptide
- Research area
- Melanocortin
- Formula
- C50H68N14O10
- Average mass
- 1,025.163 Da
- Monoisotopic mass
- 1,024.5243 Da
- Length
- 7 residues
- PubChem
- CID 9941379
What it is
Bremelanotide is a synthetic seven-residue peptide with the structure Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. Its molecular formula is C50H68N14O10, its average mass is 1025.16 g/mol and its monoisotopic mass is 1024.52. It is indexed as PubChem CID 9941379 and under the development code PT-141.
The molecule belongs to the cyclic lactam melanocortin series built from the His-Phe-Arg-Trp message sequence of alpha-melanocyte-stimulating hormone, and is described as an agonist acting mainly at the melanocortin receptor subtypes MC3R and MC4R 1.
Discovery and origin
The compound comes out of the melanocortin medicinal chemistry work of the late 1980s and 1990s, in which a linear melanotropin fragment was cyclized through a side-chain lactam bridge and then varied systematically. Bremelanotide is the C-terminal free-acid member of that series: comparing formulas, it differs from melanotan II by the replacement of the terminal carboxamide with a hydroxyl.
Structure and chemistry
The ring is closed by a lactam bridge, an amide bond between the aspartate side-chain carboxylate and the lysine side-chain amine. Unlike a disulfide, that bridge cannot be reduced open, which makes the ring robust to the reducing agents common in cell assays.
The N-terminus is acetylated, position four is D-phenylalanine, and norleucine stands in for the methionine of the native sequence, removing the thioether that would otherwise be the main oxidation liability. The free C-terminal carboxylate is the one acidic group on an otherwise basic molecule, which lowers the net charge relative to the amidated analog and gives the pair different retention in reversed-phase chromatography. The tryptophan indole absorbs near 280 nm.
How it is studied in the laboratory
Published preclinical work is mostly rodent behavior studies and cell-based receptor assays. A 2004 study examined the compound in a female rat behavior model, using melanocortin receptor antagonists to test whether the measured responses depended on that receptor family 1.
Beyond that line, the compound appears in melanocortin receptor pharmacology as a comparator ligand in binding and cyclic AMP assays. The preclinical literature on the molecule itself is limited.
Analytical notes
Identity is confirmed by liquid chromatography with mass spectrometry in positive ion mode. The expected singly protonated ion falls near m/z 1025.53 and the doubly protonated ion near m/z 513.27, calculated on the monoisotopic mass of 1024.52.
The most important analytical point is the close relationship to the amidated analog: melanotan II differs by about one mass, so a mass measurement alone is a weak identity test at low resolution, and chromatographic separation against authentic standards of both is the reliable check. Other informative impurities are the uncyclized linear precursor, which differs by the mass of water, cyclic dimers from intermolecular lactam formation, and diastereomers from epimerization at the D-phenylalanine position. Purity is assessed by reversed-phase HPLC at 280 nm or 214 nm.
Storage and handling in the laboratory
As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light. The lyophilized state is hygroscopic, so a sealed vial should reach room temperature before opening. Tryptophan-containing peptides are photosensitive, which is the main reason for excluding light.
Open questions in the literature
No experimental structure of bremelanotide bound to MC3R or MC4R has been published, so the basis of its subtype preference rests on binding and functional data. How the free-acid and amidated analogs differ in receptor engagement has not been resolved structurally either.
Identity check
A mass-spectrometry result for PT-141 (bremelanotide) should show peaks near these values. A result more than about one unit away is worth a question to the testing lab. Salt forms such as acetate or TFA do not move these peaks, though they do mean less peptide in each milligram of powder.
| Ion | Expected m/z |
|---|---|
| [M+H]+ | 1025.53 |
| [M+2H]2+ | 513.27 |
References
- Pfaus JG, Shadiack A, Van Soest T, Tse M, Molinoff P. Proceedings of the National Academy of Sciences. 2004;101(27):10201-10204. doi:10.1073/pnas.0400491101. Source
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
